Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Self-poisoning with 60 tablets of Apixaban, a pharmacokinetics case report.

Franck B, Dulaurent S, El Balkhi S, Monchaud C, Picard N, Couderc S, Marquet P, Saint-Marcoux F, Woillard JB.

Br J Clin Pharmacol. 2018 Nov 12. doi: 10.1111/bcp.13790. [Epub ahead of print]

PMID:
30421528
2.

Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.

Yazdani S, Callemeyn J, Gazut S, Lerut E, de Loor H, Wevers M, Heylen L, Saison C, Koenig A, Thaunat O, Thorrez L, Kuypers D, Sprangers B, Noël LH, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M.

Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630-6. doi: 10.1016/j.kint.2018.08.027. [Epub ahead of print]

3.

Quantification of stored red blood cell fluctuations by time-lapse holographic cell imaging.

Jaferzadeh K, Moon I, Bardyn M, Prudent M, Tissot JD, Rappaz B, Javidi B, Turcatti G, Marquet P.

Biomed Opt Express. 2018 Sep 10;9(10):4714-4729. doi: 10.1364/BOE.9.004714. eCollection 2018 Oct 1.

4.

Bacterial community structure in a sympagic habitat expanding with global warming: brackish ice brine at 85-90 °N.

Fernández-Gómez B, Díez B, Polz MF, Arroyo JI, Alfaro FD, Marchandon G, Sanhueza C, Farías L, Trefault N, Marquet PA, Molina-Montenegro MA, Sylvander P, Snoeijs-Leijonmalm P.

ISME J. 2018 Sep 18. doi: 10.1038/s41396-018-0268-9. [Epub ahead of print]

PMID:
30228379
5.

Dual action of L-Lactate on the activity of NR2B-containing NMDA receptors: from potentiation to neuroprotection.

Jourdain P, Rothenfusser K, Ben-Adiba C, Allaman I, Marquet P, Magistretti PJ.

Sci Rep. 2018 Sep 7;8(1):13472. doi: 10.1038/s41598-018-31534-y.

6.

Species dispersal and biodiversity in human-dominated metacommunities.

Shanafelt DW, Clobert J, Fenichel EP, Hochberg ME, Kinzig A, Loreau M, Marquet PA, Perrings C.

J Theor Biol. 2018 Nov 14;457:199-210. doi: 10.1016/j.jtbi.2018.08.041. Epub 2018 Sep 1.

7.

Comparative study of quantitative phase imaging techniques for refractometry of optical waveguides.

Bélanger E, Bérubé JP, de Dorlodot B, Marquet P, Vallée R.

Opt Express. 2018 Jun 25;26(13):17498-17510. doi: 10.1364/OE.26.017498.

PMID:
30119561
8.

Fully automated sample preparation procedure to measure drugs of abuse in plasma by liquid chromatography tandem mass spectrometry.

Robin T, Barnes A, Dulaurent S, Loftus N, Baumgarten S, Moreau S, Marquet P, El Balkhi S, Saint-Marcoux F.

Anal Bioanal Chem. 2018 Aug;410(20):5071-5083. doi: 10.1007/s00216-018-1159-7. Epub 2018 Jun 8.

PMID:
29947899
9.

Comment on "Population Pharmacokinetics of Mycophenolic Acid: An Update".

Woillard JB, Debord J, Marquet P.

Clin Pharmacokinet. 2018 Jun 19. doi: 10.1007/s40262-018-0687-9. [Epub ahead of print] No abstract available.

PMID:
29923171
10.

A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen.

Woillard JB, Gatault P, Picard N, Arnion H, Anglicheau D, Marquet P.

Am J Transplant. 2018 Apr 24. doi: 10.1111/ajt.14894. [Epub ahead of print]

PMID:
29689130
11.
12.

Structural patterns of the human ABCC4/MRP4 exporter in lipid bilayers rationalize clinically observed polymorphisms.

Chantemargue B, Di Meo F, Berka K, Picard N, Arnion H, Essig M, Marquet P, Otyepka M, Trouillas P.

Pharmacol Res. 2018 Jul;133:318-327. doi: 10.1016/j.phrs.2018.02.029. Epub 2018 Mar 10.

PMID:
29530601
13.

Pharmacokinetic Therapeutic Drug Monitoring of Advagraf in More Than 500 Adult Renal Transplant Patients, Using an Expert System Online.

Marquet P, Bedu A, Monchaud C, Saint-Marcoux F, Rérolle JP, Etienne I, Kamar N, Moulin B, Cassuto E, Essig M, Woillard JB.

Ther Drug Monit. 2018 Jun;40(3):285-291. doi: 10.1097/FTD.0000000000000503.

PMID:
29505493
14.

Sample and substrate preparation for exploring living neurons in culture with quantitative-phase imaging.

Lévesque SA, Mugnes JM, Bélanger E, Marquet P.

Methods. 2018 Mar 1;136:90-107. doi: 10.1016/j.ymeth.2018.02.001. Epub 2018 Feb 10. Review.

PMID:
29438830
15.

Species co-occurrence networks: Can they reveal trophic and non-trophic interactions in ecological communities?

Freilich MA, Wieters E, Broitman BR, Marquet PA, Navarrete SA.

Ecology. 2018 Mar;99(3):690-699. doi: 10.1002/ecy.2142. Epub 2018 Feb 12.

PMID:
29336480
16.

Ischemia/reperfusion-associated tubular cells injury in renal transplantation: Can metabolomics inform about mechanisms and help identify new therapeutic targets?

Barin-Le Guellec C, Largeau B, Bon D, Marquet P, Hauet T.

Pharmacol Res. 2018 Mar;129:34-43. doi: 10.1016/j.phrs.2017.12.032. Epub 2018 Jan 6. Review.

PMID:
29309901
17.

Endogenous Metabolites-Mediated Communication Between OAT1/OAT3 and OATP1B1 May Explain the Association Between SLCO1B1 SNPs and Methotrexate Toxicity.

Martinez D, Muhrez K, Woillard JB, Berthelot A, Gyan E, Choquet S, Andrès CR, Marquet P, Barin-Le Guellec C.

Clin Pharmacol Ther. 2018 Oct;104(4):687-698. doi: 10.1002/cpt.1008. Epub 2018 Jan 31.

PMID:
29285751
18.

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.

Falkowski S, Woillard JB, Postil D, Tubiana-Mathieu N, Terrebonne E, Pariente A, Smith D, Guimbaud R, Thalamas C, Rouguieg-Malki K, Marquet P, Picard N.

BMC Cancer. 2017 Dec 28;17(1):901. doi: 10.1186/s12885-017-3728-0.

19.

Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.

Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.

Pharmacol Res. 2018 Mar;129:84-94. doi: 10.1016/j.phrs.2017.12.005. Epub 2017 Dec 8.

PMID:
29229354
20.

On the proportional abundance of species: Integrating population genetics and community ecology.

Marquet PA, Espinoza G, Abades SR, Ganz A, Rebolledo R.

Sci Rep. 2017 Dec 1;7(1):16815. doi: 10.1038/s41598-017-17070-1.

21.

Innovation and the growth of human population.

Weinberger VP, Quiñinao C, Marquet PA.

Philos Trans R Soc Lond B Biol Sci. 2017 Dec 5;372(1735). pii: 20160415. doi: 10.1098/rstb.2016.0415.

PMID:
29061888
22.

Innovation: an emerging focus from cells to societies.

Hochberg ME, Marquet PA, Boyd R, Wagner A.

Philos Trans R Soc Lond B Biol Sci. 2017 Dec 5;372(1735). pii: 20160414. doi: 10.1098/rstb.2016.0414.

23.

Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition.

Noceti O, Pouché L, Esperón P, Lens D, Vital M, Touriño C, Gerona S, Woillard JB, Marquet P.

Clin Chem. 2017 Nov;63(11):1734-1744. doi: 10.1373/clinchem.2017.272534.

24.

Untargeted Screening of Urinary Peptides Using Offline Nano-Liquid Chromatography: MALDI-TOF/TOF Mass Spectrometry.

Sauvage FL, Passeron S, Marquet P.

Methods Mol Biol. 2018;1788:113-121. doi: 10.1007/7651_2017_74.

PMID:
29039148
25.

Integrating macroecology through a statistical mechanics of adaptive matter.

Marquet PA.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10523-10525. doi: 10.1073/pnas.1713971114. Epub 2017 Sep 25. No abstract available.

26.

An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.

Prémaud A, Filloux M, Gatault P, Thierry A, Büchler M, Munteanu E, Marquet P, Essig M, Rousseau A.

PLoS One. 2017 Jul 3;12(7):e0180236. doi: 10.1371/journal.pone.0180236. eCollection 2017.

27.

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation.

Woillard JB, Mourad M, Neely M, Capron A, van Schaik RH, van Gelder T, Lloberas N, Hesselink DA, Marquet P, Haufroid V, Elens L.

Front Pharmacol. 2017 Jun 8;8:358. doi: 10.3389/fphar.2017.00358. eCollection 2017.

28.

Uterus tolerance to extended cold ischemic storage after auto-transplantation in ewes.

Tricard J, Ponsonnard S, Tholance Y, Mesturoux L, Lachatre D, Couquet C, Terro F, Yardin C, Marquet P, Piccardo A, Gauthier T.

Eur J Obstet Gynecol Reprod Biol. 2017 Jul;214:162-167. doi: 10.1016/j.ejogrb.2017.05.013. Epub 2017 May 16.

PMID:
28535402
29.

Towards therapeutic drug monitoring of everolimus in cancer? Results of an exploratory study of exposure-effect relationship.

Deppenweiler M, Falkowski S, Saint-Marcoux F, Monchaud C, Picard N, Laroche ML, Tubiana-Mathieu N, Venat-Bouvet L, Marquet P, Woillard JB.

Pharmacol Res. 2017 Jul;121:138-144. doi: 10.1016/j.phrs.2017.04.029. Epub 2017 May 1.

PMID:
28473246
30.

The Lausanne-Geneva cohort study of offspring of parents with mood disorders: methodology, findings, current sample characteristics, and perspectives.

Vandeleur CL, Strippoli MF, Castelao E, Gholam-Rezaee M, Ferrero F, Marquet P, Aubry JM, Preisig M.

Soc Psychiatry Psychiatr Epidemiol. 2017 Aug;52(8):1041-1058. doi: 10.1007/s00127-017-1382-0. Epub 2017 Apr 10.

PMID:
28396906
31.

Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.

Woillard JB, Debord J, Monchaud C, Saint-Marcoux F, Marquet P.

Clin Pharmacokinet. 2017 Dec;56(12):1491-1498. doi: 10.1007/s40262-017-0533-5.

32.

Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study.

Noreikaitė A, Saint-Marcoux F, Marquet P, Kaduševičius E, Stankevičius E.

Medicine (Baltimore). 2017 Mar;96(13):e6469. doi: 10.1097/MD.0000000000006469.

33.

Extra-metabolic energy use and the rise in human hyper-density.

Burger JR, Weinberger VP, Marquet PA.

Sci Rep. 2017 Mar 2;7:43869. doi: 10.1038/srep43869.

34.

A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity.

Woillard JB, Debord J, Benz-de-Bretagne I, Saint-Marcoux F, Turlure P, Girault S, Abraham J, Choquet S, Marquet P, Barin-Le Guellec C.

Ther Drug Monit. 2017 Apr;39(2):145-156. doi: 10.1097/FTD.0000000000000381.

PMID:
28196047
35.

Anti-hepatitis C virus drugs and kidney.

Carrier P, Essig M, Debette-Gratien M, Sautereau D, Rousseau A, Marquet P, Jacques J, Loustaud-Ratti V.

World J Hepatol. 2016 Nov 18;8(32):1343-1353. Review.

36.

Performance characteristics of the Access AMH assay for the quantitative determination of anti-Müllerian hormone (AMH) levels on the Access* family of automated immunoassay systems.

Demirdjian G, Bord S, Lejeune C, Masica R, Rivière D, Nicouleau L, Denizot P, Marquet PY.

Clin Biochem. 2016 Nov;49(16-17):1267-1273. doi: 10.1016/j.clinbiochem.2016.08.005. Epub 2016 Aug 16.

37.

Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients.

Debette-Gratien M, Woillard JB, Picard N, Sebagh M, Loustaud-Ratti V, Sautereau D, Samuel D, Marquet P.

Transplantation. 2016 Oct;100(10):2129-2137.

PMID:
27653228
38.

Uterus human leucocyte antigen expression in the perspective of transplantation.

Gauthier T, Filloux M, Guillaudeau A, Essig M, Bibes R, Pacha AF, Piver P, Aubard Y, Marquet P, Drouet M.

J Obstet Gynaecol Res. 2016 Dec;42(12):1789-1795. doi: 10.1111/jog.13107. Epub 2016 Sep 19.

PMID:
27640423
39.

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.

Loustaud-Ratti V, Maynard M, Thevenon S, Pradat P, Rousseau A, Alain S, Deny P, Gagnieu MC, Tran A, Dao T, Silvain C, Lunel-Fabiani F, Picard N, Zublena I, Marquet P, Trepo C; RIBAJUSTE Group.

Ther Drug Monit. 2016 Dec;38(6):684-692.

PMID:
27559840
40.

Overview of accessibility and quality of antiepileptic drugs in Madagascar.

Nizard M, Jost J, Tanamasoandro R, Andriambololona R, Megherbi M, Solofomalala GD, Marquet P, Preux PM, Ratsimbazafy V.

Seizure. 2016 Oct;41:134-40. doi: 10.1016/j.seizure.2016.07.015. Epub 2016 Aug 1.

41.

Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.

Ben Fredj N, Woillard JB, Debord J, Chaabane A, Boughattas N, Marquet P, Saint-Marcoux F, Aouam K.

Exp Clin Transplant. 2016 Aug;14(4):394-400.

42.

Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches.

Anglicheau D, Naesens M, Essig M, Gwinner W, Marquet P.

Transplantation. 2016 Oct;100(10):2024-38. doi: 10.1097/TP.0000000000001321. Review.

PMID:
27479159
43.

Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.

Saliba F, Rostaing L, Gugenheim J, Durand F, Radenne S, Leroy V, Neau-Cransac M, Calmus Y, Salamé E, Pageaux GP, Duvoux C, Taguieva N, Sinnasse-Raymond G, Sebagh M, Samuel D, Marquet P.

Transplantation. 2016 Aug;100(8):1705-13. doi: 10.1097/TP.0000000000001228.

PMID:
27454919
44.

Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.

Tellier S, Dallocchio A, Guigonis V, Saint-Marcoux F, Llanas B, Ichay L, Bandin F, Godron A, Morin D, Brochard K, Gandia P, Bouchet S, Marquet P, Decramer S, Harambat J.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1777-1782. doi: 10.2215/CJN.00320116. Epub 2016 Jul 21.

45.

Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients.

Billat PA, Ossman T, Saint-Marcoux F, Essig M, Rerolle JP, Kamar N, Rostaing L, Kaminski H, Fabre G, Otyepka M, Woillard JB, Marquet P, Trouillas P, Picard N.

Pharmacol Res. 2016 Sep;111:501-508. doi: 10.1016/j.phrs.2016.07.012. Epub 2016 Jul 9. Review.

PMID:
27402191
46.

In silico pharmacology: Drug membrane partitioning and crossing.

Di Meo F, Fabre G, Berka K, Ossman T, Chantemargue B, Paloncýová M, Marquet P, Otyepka M, Trouillas P.

Pharmacol Res. 2016 Sep;111:471-486. doi: 10.1016/j.phrs.2016.06.030. Epub 2016 Jul 1. Review.

PMID:
27378566
47.

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.

Dalenc F, Iuliano L, Filleron T, Zerbinati C, Voisin M, Arellano C, Chatelut E, Marquet P, Samadi M, Roché H, Poirot M, Silvente-Poirot S.

J Steroid Biochem Mol Biol. 2017 May;169:210-218. doi: 10.1016/j.jsbmb.2016.06.010. Epub 2016 Jun 22.

PMID:
27343991
48.

Therapist Adherence to Good Psychiatric Practice in a Short-Term Treatment for Borderline Personality Disorder.

Kolly S, Despland JN, de Roten Y, Marquet P, Kramer U.

J Nerv Ment Dis. 2016 Jul;204(7):489-93. doi: 10.1097/NMD.0000000000000481.

PMID:
27187770
49.

Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder.

Paccalet T, Gilbert E, Berthelot N, Marquet P, Jomphe V, Lussier D, Bouchard RH, Cliche D, Gingras N, Maziade M.

Schizophr Res. 2016 Aug;175(1-3):186-192. doi: 10.1016/j.schres.2016.04.038. Epub 2016 May 6.

PMID:
27160791
50.

Erratum to Araújo et al (2013).

Araújo MB, Ferri-Yáñez F, Bozinovic F, Chown SL, Marquet PA.

Ecol Lett. 2016 May;19(5):591-2. doi: 10.1111/ele.12597. Epub 2016 Mar 11. No abstract available.

PMID:
27040900

Supplemental Content

Loading ...
Support Center